Scotiabank Initiates Coverage On Janux Therapeutics with Sector Perform Rating, Announces Price Target of $47
Portfolio Pulse from Benzinga Newsdesk
Scotiabank has initiated coverage on Janux Therapeutics with a Sector Perform rating and set a price target of $47.
May 30, 2024 | 2:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank has initiated coverage on Janux Therapeutics with a Sector Perform rating and set a price target of $47.
The initiation of coverage by a major bank like Scotiabank and the setting of a price target can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100